Sponsored Clinical trial aims to personalize treatment for patients with HPV-related throat cancerBlood-based protocol could reduce treatment burden while preserving quality of life after surgery November 13, 2026Vol.52 No.42By Hayley Kamin
Sponsored Community sites have the patients to boost trial enrollment—but not the infrastructure November 06, 2026Vol.52 No.41By Gordon Harris
Sponsored Lifesaving vaccines: Using KRAS to harness the power of the immune system October 30, 2026Vol.52 No.40By Valerie Mehl
Sponsored Moving beyond escalation to a new therapeutic strategy in oncologyMicrobiome-based treatment may offer a different approach October 23, 2026Vol.52 No.39By Sumanta Pal
Sponsored Beyond BRCA: Using AI to uncover the hidden architecture of hereditary cancer risk October 16, 2026Vol.52 No.38By Fox Chase Cancer Center
Sponsored MUSC startup brings preclinical imaging into the lightNew technology lets cancer researchers watch experiments unfold in real time October 09, 2026Vol.52 No.37By Hayley Kamin
Sponsored ASCO Genitourinary Cancers Symposium: Pioneering breakthroughs, optimizing patient outcomes October 02, 2026Vol.52 No.36By The American Society of Clinical Oncology
Sponsored The end of “more money, more people, more trials”Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. September 18, 2026Vol.52 No.34By Jeff Sorenson
Sponsored UK Markey’s Tim Mullett: How the Markey Affiliate Network brings NCI-level cancer care to every corner of Kentucky September 11, 2026Vol.52 No.33By University of Kentucky Markey Cancer Center